Parallel Advisors, LLC Acelrx Pharmaceuticals Inc Transaction History

Parallel Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$1.25 - $2.77 $2,500 - $5,540	-2,000 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$1.18 - $1.98 $1,652 - $2,772	-1,400 Reduced 41.18%	2,000 $2,000
Q2 2020 Jul 16, 2020	SELL	$1.03 - $1.69 $635 - $1,042	-617 Reduced 15.36%	3,400 $4,000
Q3 2019 Nov 01, 2019	BUY	$2.1 - $2.87 $8,435 - $11,528	4,017 New	4,017 $9,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.